Scientific Advisory Board

The Institute's Scientific Advisory Board meets every 18 months to discuss our strategy and progress with the Director, Deputy Director and other members of the senior management team.

Scientific Advisory Board

Margaret Frame (Chair)

University of Edinburgh, UK

David Adams

Sanger Institute, UK

Simon Barry

AstraZeneca, Cambridge, UK

Karin de Visser

NKI, Amsterdam, The Netherlands

Rebecca Fitgerald

University of Cambridge, UK

Johanna Ivaska

University of Turku, Finland

Louise Jones

Barts Cancer Institute, London, UK

Jos Jonkers

NKI, Amsterdam, The Netherlands

Alec Kimmelman

NYU Langone Health, New York, USA

Ultan McDermott

AstraZeneca, Cambridge, UK

Ian Tomlinson

University of Edinburgh, UK